Sign In
Buy SLGL
$71.50
-2.23 (-3.02%)
At Close: Jun 03, 2026
Sol-Gel Announces Pipeline Update and Future Development Plans
05:10am, Monday, 28'th Jun 2021
NESS ZIONA, Israel, June 28, 2021 (GLOBE NEWSWIRE) -- Sol-Gel Technologies, Ltd. (NASDAQ: SLGL), a clinical-stage dermatology company focused on identifying, developing and commercializing branded and
NESS ZIONA, Israel & LAUSANNE, Switzerland--(BUSINESS WIRE)--Sol-Gel Technologies, Ltd. (NASDAQ: SLGL), a clinical-stage dermatology company, and Galderma, the world's largest independent dermatology
Sol-Gel Technologies Reports First Quarter 2021 Financial Results and Corporate Update
07:05am, Thursday, 13'th May 2021
- Sol-Gel is in advanced negotiations with a potential partner regarding the commercialization of EPSOLAY ® and TWYNEO ®
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Sol-Gel Technologies Ltd. - SLGL
08:41pm, Wednesday, 28'th Apr 2021
New York, New York--(Newsfile Corp. - April 28, 2021) - Pomerantz LLP is investigating claims on behalf of investors of Sol-Gel Technologies Ltd. ("Sol-Gel" or the "Company") (NASDAQ: SLGL) Such inves
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Sol-Gel Technologies Ltd. - SLGL
01:22am, Wednesday, 28'th Apr 2021
NEW YORK, April 28, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Sol-Gel Technologies Ltd. ("Sol-Gel" or the "Company") (NASDAQ: SLGL) Such investors are adv
Sol-Gel Technologies Provides Update on FDA Review of EPSOLAY®
10:02am, Tuesday, 27'th Apr 2021
NESS ZIONA, Israel, April 27, 2021 (GLOBE NEWSWIRE) -- Sol-Gel Technologies, Ltd. (NASDAQ: SLGL), a clinical-stage dermatology company focused on identifying, developing and commercializing branded an
SolGel Technologies Ltd. (SLGL) Moves 9.7% Higher: Will This Strength Last?
03:02am, Friday, 16'th Apr 2021
SolGel Technologies Ltd. (SLGL) was a big mover last session on higher-than-average trading volume.
SolGel Technologies Ltd. (SLGL) Stock Jumps 10.8%: Will It Continue to Soar?
12:07pm, Thursday, 11'th Mar 2021
SolGel Technologies Ltd. (SLGL) witnessed a jump in share price last session on above-average trading volume.
SolGel Technologies Ltd. (SLGL) Reports Q4 Loss, Lags Revenue Estimates
09:53am, Thursday, 04'th Mar 2021
SolGel Technologies Ltd. (SLGL) delivered earnings and revenue surprises of 12.20% and -725.03%, respectively, for the quarter ended December 2020.
Sol-Gel Technologies Reports Full Year 2020 Financial Results and Corporate Update
07:05am, Thursday, 04'th Mar 2021
• Epsolay ® and Twyneo ® PDUFA goal date s set for April 26 , 2021 and August 1 , 2021 respectively
NESS ZIONA, Israel, Feb. 24, 2021 (GLOBE NEWSWIRE) -- Sol-Gel Technologies (NASDAQ: SLGL), (“Sol-Gel”), a clinical-stage dermatology company focused on identifying, developing and commercializing
NESS ZIONA, Israel, Jan. 11, 2021 (GLOBE NEWSWIRE) -- Sol-Gel Technologies (NASDAQ: SLGL), (“Sol-Gel”), a clinical-stage dermatology company focused on identifying, developing and commercializing
Sol-Gel Technologies Announces FDA Acceptance for Filing of New Drug Application for Twyneo® for the Treatment of Acne Vulgaris
07:05am, Monday, 07'th Dec 2020
- PDUFA Goal Date Set for August 1, 2021
Sol-Gel: Slow And Steady Topical Technology
09:00am, Thursday, 19'th Nov 2020
Patented technology for slow release of topical formulations. Potentially the first single-active benzoyl peroxide to be approved as a prescription drug.
Sol-Gel to Present at Upcoming Healthcare Investor Conferences in November 2020
07:05am, Monday, 09'th Nov 2020
NESS ZIONA, Israel, Nov. 09, 2020 (GLOBE NEWSWIRE) -- Sol-Gel Technologies (NASDAQ: SLGL), (“Sol-Gel”), a clinical-stage dermatology company focused on identifying, developing and commercializing
